Anthony J. Sinskey - 30 Sep 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Role
Director
Signature
Charles B. Haaser, attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 Sep 2022
Net transactions value
+$7,814
Form type
4
Filing time
03 Oct 2022, 16:41:28 UTC
Previous filing
17 Aug 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $7,814 +2,761 $2.83* 2,761 30 Sep 2022 Common Stock 2,761 $2.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $7,813 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the third quarter of 2022.